SCHEMBL689189

SCHEMBL689189

CCCCc1ccc2c(c1)CC(=O)N2

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.50
MAOB P27338 3/20 0.49
HTR1A P08908 7/20 0.46
DRD2 P14416 6/20 0.46
HTR2A P28223 6/20 0.46
ADRA1D P25100 1/20 0.46
ADRA1A P35348 1/20 0.46
ADRA1B P35368 1/20 0.46
GRIA1 P42261 2/20 0.46
CACNG8 Q8WXS5 2/20 0.46
PDE3B Q13370 1/20 0.45
PDE3A Q14432 1/20 0.45
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
SMYD3 Q9H7B4 1/20 0.44
PDK2 Q15119 1/20 0.43
EPHX2 P34913 1/20 0.43
PGR P06401 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1460158 0.95 AHR (0.49) AHRMAOBHTR1ADRD2HTR2A
SCHEMBL7349900 0.90 AHR (0.53) AHRMAOBHTR1ADRD2HTR2A
SCHEMBL4481831 0.90 PDE3B (0.56) AHRMAOBGRIA1CACNG8PDE3B
SCHEMBL19991984 0.88 AHR (0.50) AHRMAOBHTR1ADRD2HTR2A
SCHEMBL8670836 0.87 AHR (0.59) AHRMAOBHTR1ADRD2HTR2A
SCHEMBL4481829 0.85 PGR (0.58) AHRHTR1ADRD2HTR2AADRA1D
SCHEMBL5728887 0.84 AHR (0.54) AHRMAOBHTR1ADRD2HTR2A
SCHEMBL578518 0.83 AHR (0.56) AHRMAOBHTR1ADRD2HTR2A
SCHEMBL7121335 0.83 AHR (0.56) AHRMAOBHTR1ADRD2HTR2A
SCHEMBL4889909 0.83 AHR (0.53) AHRMAOBHTR1ADRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102702068-B 3-pyrrolo-cyclohexylidene-2-dihydroindolone derivative, and application of 3-pyrrolo-cyclohexylidene-2-dihydroindolone derivative NANJING YOKO BIOLOG PHARMACEUTICAL RES CO LTD 2014-05-14 CN disclosed
CN-101389624-B 3-pyrrolocyclohexylidene-2-indolinone derivative and application thereof JIANGSU SIMCERE PHARM RES CO 2012-10-03 CN disclosed
CN-102702068-A 3-pyrrolo-cyclohexylidene-2-dihydroindolone derivative, and application of 3-pyrrolo-cyclohexylidene-2-dihydroindolone derivative JIANGSU SIMCERE PHARM RES CO 2012-10-03 CN disclosed
EP-2123649-B1 3-PYRROLO-CYCLOHEXYLENE-2-DIHYDRO-INDOLINONE DERIVATIVES AND USES THEREOF JIANGSU SIMCERE PHARMACEUTICAL R & D CO LTD (CN) 2012-02-29 EP disclosed
US-8084621-B2 3-Pyrrolo[b]cyclohexylene-2-dihydroindolinone derivatives and uses thereof Jiangsu Simcere Pharmaceutical R&D Co. Ltd. (CN) 2011-12-27 US disclosed
US-20100160318-A1 3-Pyrrolo[b]Cyclohexylene-2-Dihydroindolinone Derivatives and Uses Thereof JIANGSU SIMCERE PHARMACEUTICAL R&D CO., LTD. (CN) 2010-06-24 US disclosed
EP-2123649-A1 3-PYRROLO-CYCLOHEXYLENE-2-DIHYDRO-INDOLINONE DERIVATIVES AND USES THEREOF Jiangsu Simcere Pharmaceutical R&D Co., Ltd. (CN) 2009-11-25 EP disclosed
CN-101389624-A 3-pyrrolocyclohexylidene-2-indolinone derivative and application thereof JIANGSU SIMCERE PHARMACEUTICAL (CN) 2009-03-18 CN disclosed
EP-2020408-A1 Pyrrole substituted 2-indolinone protein kinase inhibitors Sugen, Inc. (US) 2009-02-04 EP disclosed
CN-101200446-A 3-pyrrole ring caproic subunit-2-dihydroindolone derivatives and uses thereof JIANGSU SIMCERE PHARMACEUTICAL (CN) 2008-06-18 CN disclosed
US-4665194-A ANALGESICS, ANTIINFLAMMATORY AGENTS PFIZER INC. (US) 1987-05-12 US disclosed
US-4658037-A RHEUMATIC DISEASES PFIZER INC. (US) 1987-04-14 US disclosed
US-4652658-A Process for making 2-oxindole-1-carboxamides and intermediates therefor PFIZER INC. (US) 1987-03-24 US disclosed
EP-0175551-A1 Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds PFIZER INC. (US) 1986-03-26 EP disclosed
US-4569942-A N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents PFIZER INC. (US) 1986-02-11 US disclosed
EP-0164860-A1 N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents PFIZER INC. (US) 1985-12-18 EP disclosed
US-4556672-A 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents PFIZER INC. (US) 1985-12-03 US disclosed
EP-0156603-A2 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents PFIZER INC. (US) 1985-10-02 EP disclosed
EP-0155828-A2 Process for making 2-oxindole-1-carboxamides and intermediates therefor PFIZER INC. (US) 1985-09-25 EP disclosed
EP-0153818-A2 1,3-Disubstituted 2-oxindoles as analgesic and anti-inflammatory agents PFIZER INC. (US) 1985-09-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160318-A1 3-Pyrrolo[b]Cyclohexylene-2-Dihydroindolinone Derivatives and Uses Thereof PTK2B, DMPK, STK25 AHR 1528/4885MAOB 1059/4885HTR1A 3541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.